Opportunity Information: Apply for W81XWH 09 ARP CTA
Apply for W81XWH 09 ARP CTA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Autism Research Program Clinical Trial Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Jun 18, 2009 and posted on Feb 1, 2009.
- Applicants must submit their applications by Aug 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,200,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Autism Research Program (ARP) Clinical Trial Award (CTA) is a U.S. Department of the Army funding opportunity administered through the Congressionally Directed Medical Research Programs (CDMRP) to support well-designed clinical trials that could make a meaningful, near-term difference in how autism spectrum disorder (ASD) is treated or managed. The central purpose of this mechanism is practical clinical impact: it is meant to move beyond exploratory work and directly test interventions in people, with the goal of improving outcomes for individuals with ASD and addressing urgent needs identified by the autism community. A key restriction is that funds cannot be used for preclinical studies, such as animal or laboratory experiments intended to justify moving into humans. Applicants are expected to propose an actual clinical trial, and the program directs investigators to CDMRP guidance (notably Appendix 6 in the Application Instructions and General Information) to help distinguish a true clinical trial from other forms of clinical research.
A defining feature of this award is its emphasis on speed to implementation. The proposed clinical trial is expected to begin no later than 12 months after the award date, which signals that the program is looking for teams that are ready to launch: protocols should be mature, operational plans should be realistic, and sites, recruitment strategies, and regulatory pathways should be sufficiently developed to avoid long delays. This also implies that the trial concept should be feasible within the award period and budget, with clear milestones that reflect real-world trial start-up requirements such as IRB review, contracting, staff training, and data management setup.
For fiscal year 2009, the ARP highlighted two priority research areas. The first is comorbidity, meaning the many co-occurring medical and functional issues that frequently accompany ASD and can substantially affect quality of life and day-to-day functioning. The announcement lists examples including gastrointestinal problems, sleep disorders, behavioral challenges, speech and language issues, psychiatric conditions, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and the ways ASD can affect intellectual ability. Clinical trials responsive to this area would typically test interventions that prevent, reduce, or better manage these co-occurring conditions, or that tailor ASD management strategies to account for them.
The second priority area is predictors for treatment outcome, focusing on identifying biomarkers, clinical characteristics, or other phenotypic markers that can forecast whether a person is likely to benefit from a particular treatment. This includes predictors relevant to traditional interventions as well as complementary and alternative approaches. In practice, this could mean clinical trials that incorporate stratification factors, collect biological samples or behavioral measures to identify response signatures, or test whether specific subgroups respond differently. The goal is to move the field toward more personalized and efficient care by learning not only whether an intervention works on average, but also for whom it works, under what conditions, and who is unlikely to respond.
From an administrative standpoint, this opportunity was posted February 1, 2009 (Funding Opportunity Number W81XWH-09-ARP-CTA) and offered support through either grants or cooperative agreements, under the science and technology/research and development category. The estimated total funding was $2.2 million, with an expectation of making about two awards. There was no cost-sharing or matching requirement, and eligibility was described as unrestricted, meaning a wide range of applicant organization types could apply as long as they met any clarifications in the full announcement. The CFDA number associated with the program is 12.420 (Military Medical Research and Development). The original application closing date was July 22, 2009, later extended to August 19, 2009, and the opportunity was archived on August 21, 2009.
For applicants needing help accessing the full announcement or navigating submission systems, the notice provided support contacts including PA HELP (301-619-7079; cdmrp.pa@amedd.army.mil), eReceipt HELP (301-682-5507; help@cdmrp.org), and the CDMRP Help Desk.
FAQs: DoD Autism Research Program (ARP) Clinical Trial Award (CTA)
What is the DoD Autism Research Program (ARP) Clinical Trial Award (CTA)?
The ARP Clinical Trial Award (CTA) is a U.S. Department of the Army funding opportunity administered through the Congressionally Directed Medical Research Programs (CDMRP). It supports well-designed clinical trials intended to make a meaningful, near-term difference in how autism spectrum disorder (ASD) is treated or managed.
What is the main goal of this award mechanism?
The central purpose is practical clinical impact. The mechanism is intended to move beyond exploratory efforts and directly test interventions in people, with the goal of improving outcomes for individuals with ASD and addressing urgent needs identified by the autism community.
Does this award fund preclinical research (animal or lab studies)?
No. A key restriction is that funds cannot be used for preclinical studies, including animal experiments or laboratory studies intended to justify moving into human testing.
Do applicants need to propose an actual clinical trial?
Yes. Applicants are expected to propose an actual clinical trial, not another form of clinical research. The program points investigators to CDMRP guidance (including Appendix 6 in the Application Instructions and General Information) to help distinguish a true clinical trial from other types of clinical studies.
How quickly is the clinical trial expected to start after an award is made?
The proposed clinical trial is expected to begin no later than 12 months after the award date. This reflects an emphasis on speed to implementation and readiness to launch.
What does “ready to launch†imply for applicants?
It implies that protocols should be mature, operational plans should be realistic, and trial logistics such as sites, recruitment strategies, and regulatory pathways should be sufficiently developed to avoid long delays.
What kinds of trial startup activities are implied by the “begin within 12 months†expectation?
The description indicates that milestones should reflect real-world startup needs, such as IRB review, contracting, staff training, and data management setup.
What were the FY2009 ARP priority research areas for this opportunity?
For fiscal year 2009, the ARP highlighted two priority areas: (1) comorbidity in ASD, and (2) predictors for treatment outcome.
What does “comorbidity†mean in the context of ASD for this funding opportunity?
Comorbidity refers to co-occurring medical and functional issues that frequently accompany ASD and can substantially affect quality of life and day-to-day functioning.
What examples of comorbidities were listed in the announcement?
Examples included gastrointestinal problems, sleep disorders, behavioral challenges, speech and language issues, psychiatric conditions, seizures, immune dysfunction, motor and sensory deficits, metabolic dysfunction, and ways ASD can affect intellectual ability.
What kinds of clinical trials would be responsive to the comorbidity priority area?
Trials would typically test interventions that prevent, reduce, or better manage co-occurring conditions, or that tailor ASD management strategies to account for these co-occurring issues.
What are “predictors for treatment outcome†in this opportunity?
This priority area focuses on identifying biomarkers, clinical characteristics, or other phenotypic markers that can forecast whether a person is likely to benefit from a particular treatment.
Do predictors include complementary and alternative interventions?
Yes. The description specifies that predictors may be relevant to traditional interventions as well as complementary and alternative approaches.
How might a clinical trial incorporate predictors for treatment outcome?
Examples described include incorporating stratification factors, collecting biological samples or behavioral measures to identify response signatures, or testing whether specific subgroups respond differently.
What is the intended impact of studying predictors for treatment outcome?
The goal is to move toward more personalized and efficient care by learning not only whether an intervention works on average, but also for whom it works, under what conditions, and who is unlikely to respond.
What is the Funding Opportunity Number for this award?
The Funding Opportunity Number is W81XWH-09-ARP-CTA.
When was this opportunity posted?
It was posted on February 1, 2009.
What types of funding instruments were available?
Support was offered through either grants or cooperative agreements.
What was the program category listed for this opportunity?
The category was science and technology/research and development.
How much total funding was estimated for this opportunity?
The estimated total funding was $2.2 million.
How many awards were expected to be made?
The announcement indicated an expectation of making about two awards.
Was cost sharing or matching required?
No. There was no cost-sharing or matching requirement.
Who was eligible to apply?
Eligibility was described as unrestricted, meaning a wide range of applicant organization types could apply, subject to any clarifications in the full announcement.
What CFDA number was associated with this program?
The CFDA number is 12.420 (Military Medical Research and Development).
What was the original application closing date, and was it extended?
The original closing date was July 22, 2009, and it was later extended to August 19, 2009.
When was the opportunity archived?
The opportunity was archived on August 21, 2009.
Where can applicants get help with the announcement or submission systems?
The notice listed support contacts including PA HELP (301-619-7079; cdmrp.pa@amedd.army.mil), eReceipt HELP (301-682-5507; help@cdmrp.org), and the CDMRP Help Desk.
Browse more opportunities from the same agency: Dept. of the Army USAMRAA
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Autism Research Program Idea Award
Previous opportunity: Space Based Advanced Sensing and Protection Branch Open 5 Year Broad Agency Announcement
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 09 ARP CTA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 09 ARP CTA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Autism Research Program Idea Award Apply for W81XWH 09 ARP IDEA Funding Number: W81XWH 09 ARP IDEA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Robotics Collaborative Technology Alliance (CTA) Apply for W911NF 08 R 0012 Funding Number: W911NF 08 R 0012 Agency: Dept of the Army Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $209,700,000 |
| Microsystems Technology Apply for DARPA BAA 08 18 PDF Funding Number: DARPA BAA 08 18 PDF Agency: DARPA Microsystems Technology Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cognition and Neuroergonomics (CAN) Collaborative Technology Alliance (CTA) Apply for W911NF 08 R 0014 Funding Number: W911NF 08 R 0014 Agency: Dept of the Army Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $130,000,000 |
| DoD Breast Cancer Idea Award Apply for W81XWH 09 BCRP IDEA Funding Number: W81XWH 09 BCRP IDEA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer Era of Scholar Award Apply for W81XWH 09 BCRP EOHS Funding Number: W81XWH 09 BCRP EOHS Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Neurofibromatosis Postdoctoral Traineeship Award Apply for W81XWH 09 NFRP POSTDOC Funding Number: W81XWH 09 NFRP POSTDOC Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer HBCU/MI Partnership Training Award Apply for W81XWH 09 BCRP HPT Funding Number: W81XWH 09 BCRP HPT Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer Innovator Award Apply for W81XWH 09 BCRP INNOV Funding Number: W81XWH 09 BCRP INNOV Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Neurofibromatosis Exploration Hypothesis Development Award Apply for W81XWH 09 NFRP EHDA Funding Number: W81XWH 09 NFRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Neurofibromatosis New Investigator Award Apply for W81XWH 09 NFRP NIA Funding Number: W81XWH 09 NFRP NIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Tuberous Sclerosis Complex Exploration Hypothesis Development Award Apply for W81XWH 09 TSCRP EHDA Funding Number: W81XWH 09 TSCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Tuberous Sclerosis Complex Career Transition Award Apply for W81XWH 09 TSCRP CARTA Funding Number: W81XWH 09 TSCRP CARTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 1 High Energy Lasers Fiber Development and Improvement Apply for BAA 09 11 PKM CALL1 Funding Number: BAA 09 11 PKM CALL1 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 2 Optical Isolation Apply for BAA 09 11 PKM CALL2 Funding Number: BAA 09 11 PKM CALL2 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 3 Mid Infrared Laser Source and Laser Development Apply for BAA 09 11 PKM CALL3 Funding Number: BAA 09 11 PKM CALL3 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 4 High Power Microwave Windows First Category Window Apply for BAA 09 11 PKM CALL4 Funding Number: BAA 09 11 PKM CALL4 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 5 High Power Microwave Windows Second Category Window Apply for BAA 09 11 PKM CALL5 Funding Number: BAA 09 11 PKM CALL5 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| GLANSER Geospatial Location Accountability Navigation System for Emergency Responders Apply for BAA09 02 Funding Number: BAA09 02 Agency: Office of Procurement Operations Grants Division Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Funding Opportunity Notice for FY 2009 SBIR/STTR Phase II Grant Applications Apply for DE PS02 09ER09 09 Funding Number: DE PS02 09ER09 09 Agency: Chicago Service Center Category: Science and Technology and other Research and Development Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 09 ARP CTA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
